Trial intelligence / Profile preview

Early intervention with nifedipine controlled-release tablets in mild hypertension with elevated pulse wave velocity

ChiCTR-ONC-13004063Phase 4Completed

Sponsor
The Second Hospital of Hebei Medical University
Start
Jan 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of nifedipine in hypertension (HTN), sponsored by The Second Hospital of Hebei Medical University. Primary endpoint: Pulse wave velocity. Started Jan 2014; status: completed.

02

Drugs

nifedipine
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on ChiCTR-ONC-13004063.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-ONC-13004063.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call